Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The two screenshots show only minor UI tweaks with no changes to core study content, eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:50:03.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    New operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.
    Difference
    3%
    Check dated 2025-10-05T08:07:13.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T02:59:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, signaling a minor update or bug fix. The removal of the 'Back to Top' link is a minor navigational change with no impact on core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:37:08.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:58:58.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of various biochemical terms related to proteins and organic chemicals. However, several key terms and resources related to genetic diseases and immunological agents have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:45:53.000Z thumbnail image

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.